FDA Approves New Treatment Option For Glioma

In an era when targeted therapies are often effective against multiple types of cancer, the U.S. Food and Drug Administration’s accelerated approval of a two-drug therapy for solid tumors carrying a specific mutation in the BRAF gene is a prime example of this trend. For patients with glioma brain cancer that harbors the mutation, the … Read more

Advances in Myeloma, Breast Cancer, and Clinical Trials Equity: A Dana-Farber Research Update

Results of several phase 3 trials and dozens of other studies led by Dana-Farber researchers were presented online and in person June 3-7 at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO), the world’s largest clinical cancer research meeting. Some of the research reports presented by Dana-Farber investigators include: Improved progression-free … Read more

For Afghanistan War Veteran, Immunotherapy Makes Gains Against Brain Cancer

A compound that sparks an immune system attack on cancer while also lowering tumor cells’ defenses against such an attack is showing promise in its first clinical trial in patients with advanced or metastatic cancers. One of those with the best result is a former U.S. Marine and Afghanistan war veteran, Josh Mahoney. Mahoney, of … Read more

Glioblastoma Patient Enjoys Steady Health and New Adventures

If you happened to be looking for Alex Epshteyn this past winter, you might have found him on the ski slopes. The Charlestown, Massachusetts resident took up the sport just two years ago and has since been enthusiastically sharpening his skills. “I’m overcoming my fear and making progress, which is a great feeling,” Epshteyn says. … Read more

Drugs Targeting a Pathway in Glioblastoma Must Clear a High Bar, Study Suggests

Researchers had every reason to expect that a compound called BKM120 (also known as buparlisib) would stifle glioblastoma brain tumors lacking the protein PTEN. After all, it was known to block the tumor-promoting PI3K protein and could easily pass through the blood-brain barrier — the dense layer of cells that guards entry to the brain … Read more

For Mother and Son, Brain Cancer Treatment Is All In The Family

Upon learning she had brain cancer in early 2016, Connie Etheridge immediately thought, “Thank goodness it’s me, and not my children.” Then, three months later, her son Trevor, 23, found out he too had brain cancer. It was a devastating double diagnosis, but the Etheridges have been by each other’s side through check-ups, radiation, and … Read more

Avastin Helps Patients with Glioblastomas, Doctors Say

The drug Avastin, when added to initial therapy for glioblastoma, can give patients a few extra months’ reprieve before their brain tumors start growing again, but does it make their quality of life better – or worse?

That’s a matter of heated debate for doctors – and confusion for patients – after two large clinical trials reported conflicting results at the annual American Society of Clinical Oncology (ASCO) conference in June. Some experts contend that Avastin lacked sufficient benefit for use as an “upfront” treatment for glioblastomas – the most common and aggressive brain tumors.

Read more